ViiV Healthcare’s HIV treatment Cabenuva was approved by the U.S. Food and Drug Administration for use every two months, meaning patients only have to receive an injectable dose six times per year.
The United States government procured more than 100 million additional COVID-19 tests from testmaker iHealth Lab Inc. as part of the White House’s plan to distribute 500 million free at-home tests across the country, the Department of Defense said Jan. 28.
U.S. cities and counties have embraced a proposed settlement worth up to $26 billion resolving lawsuits alleging three large drug distributors and drugmaker Johnson & Johnson fueled the U.S. opioid epidemic, lawyers behind the deal said on January 26, increasing the odds that it will move forward.
An appeals court judge on Jan. 25 granted a stay in an appeal over mask mandates in New York, keeping the rule in effect during the legal process, New York Attorney General Letitia James said.
The MIT Center for Collective Intelligence and MilliporeSigma brought together the thought-power of gurus in science, healthcare, public policy and other sectors to answer the question: how do we apply what we have learned from the COVID-19 pandemic for the future?
A New York judge struck down the state’s mask mandate on Jan. 24, one week before it was due to expire, ruling the governor overstepped her authority in imposing a rule that needed to have been passed by the state legislature.
A judge in Texas ruled on January 21 that President Joe Biden could not require federal employees to be vaccinated against the coronavirus and blocked the U.S. government from disciplining employees who failed to comply.
GlaxoSmithKline and U.S. partner Vir Biotechnology will boost production of their antibody-based COVID-19 treatment by adding a second manufacturing plant to help meet soaring demand in the United States.
The United States – the World Health Organization’s top donor – is resisting proposals to make the agency more independent, four officials involved in the talks said, raising doubts about the Biden administration’s long-term support for the U.N. agency.
The Biden administration is preparing for future variants of COVID-19, White House chief of Staff Ron Klain told MSNBC in an interview that aired on January 20 as the Omicron-related wave of cases appeared to be easing in parts of the United States.